Glaxosmithkline Pakistan Limited · PSX:GLAXO
Glaxosmithkline Pakistan — Corporate Update (November 2024)
14 slides from Glaxosmithkline Pakistan's corporate update, Nov 12, 2024
Slide 1: Slide 1
Slide 2: Meeting link and Q&A via Vevox
Meeting link and Q&A via Vevox MS Team Link for https://teams.microsoft.com/l/meetup- Attendees join/19%3ameeting_YjFlYTcxM2ItNWVlZi00MGIzLTgzYWQtYzg4MTA2ZWIxMzc5% 40thread.v2/0?context=%7b%22Tid%22%3a%2263982aff-fb6c-4c22-973b- 70e4acfb63e6%22%2c%22Oid%22%3a%22d50ce047-1614-41b7-9379- cf569a14071f%
Slide 3: Agenda
Agenda Economic Overview Company Overview PSX Corporate Briefing -2024 OurFinancial Achievements Outline Questions & Answers 12 November 2024 3
Slide 4: Economic Overview
Economic Overview @® ask.com
Slide 5: Economic Overview
Economic Overview CPI inflation % Monetary Policy Rate % 36.4 38.0 35.4 31.6 31.4 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 22.0 29.4 28.3 20.0 21.0 21.0 19.5 19.5 28.3 27.6 27.4 20.5 17.0 17.0 17.5 23.1 20.7 17.3 11.8 12.6 11.1 9.6 6.9 Jan Feb Mar Apr May Jun Jul Aug Sep Jan Feb Mar Apr May Jun Jul A
Slide 6: Economic Overview
Economic Overview KSE – 100 (monthly average) Monthly Exchange Rates 78.4 77.9 78.5 81.1 285.5 286.0 281.6 294.5 297.9 75.9 278.5 281.1 287.3 71.1 280.7 279.4 278.6 278.7 278.7 278.8 278.5 67.0 267.3 278.3 62.0 64.6 235.3 48.0 45.1 46.3 40.7 40.5 40.0 41.6 41.3 41.3 Jan Feb Mar Apr May Jun Jul Aug S
Slide 7: Company Overview
OSX Company Overview @® ask.com
Slide 8: Board of Directors
Board of Directors Ms. Lai Kuen Goh Ms. Erum Shakir Mr. Hasham Baber Ms. Maheen Rahman Mr. Muneer Kamal Mr. Mehmood Mr. Simon Foster (Chairperson) Rahim (Chief Financial Officer) (Independent Director) (Independent Director) Mandviwalla (Non-Executive Director) (Chief Executive Officer) (Non-Executi
Slide 9: We unite science, technology and talent to get ahead of disease together
Our purpose We unite science, technology and talent to get ahead of disease together 06 November 2024 9
Slide 10: How we'll get Ahead Together
How we’ll get Ahead Together Our culture and thriving GSK people Ambitious We’re investing in innovation and growth at pace to achieve for patients health impact at scale Accountable We set focused objectives with for impact clear measures of success Do the right thing We act responsibly and aim to
Slide 11: Financial Outline
Financial Outline @® ask.com
Slide 12: Key financial highlights
Key financial highlights Sep 30, Sep 30, 2024 2023 Net sales Rs. 43.6 b Rs. 37.0 b Gross profit Rs. 9.5 b Rs. 2.6 b Gross margin 21.9% 7.1% Profit / (loss) after tax Rs. 3.6 b Rs. (0.4 b) Earning per share Rs. 11.25 Rs. (1.23) 12 November 2024 12
Slide 13: Key Financial Ratios
Key Financial Ratios Sep 30, Sep 30, Ratios 2024 2023 Return on equity 14.2% -1.9% Current Ratio 1.68 1.58 Inventory days 125 103 Receivable days 4 8 Payable days 66 46 12 November 2024 13
Slide 14: Questions & Answers
uestions & Answers @® ask.com
GlaxoSmithKline Pakistan — Corporate Update (November 2024) on 6ix